Skip to search formSkip to main contentSkip to account menu

BXL628

Known as: BXL-628 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Calcitriol

Narrower (1)

Elocalcitol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
1,25-(OH)2D3 and its analogue BXL-628 inhibit high glucose-induced activation of RhoA/ROCK pathway in HK-2 cells.
It has previously been reported that 1,25-(OH)2D3 inhibits high glucose-induced epithelial-to-mesenchymal transition (EMT) in HK… 
2017
2017
The vitamin D analogue BXL-628 improves contraction development ex vivo in bladders of aged mice
2016
2016
The Vitamin D analogue Bxl-628 alters excitation contraction coupling in the isolated bladder in aged wildtype mice differently compared to bladders from age-matched transgenic Alzheimer’s disease…
Hypothesis / aims of study This is the first study to provide insights into the mechanisms involved in dysregulation of the… 
2008
2008
Elocalcitol (BXL-628): a novel, investigational therapy for the therapeutic management of benign prostatic hyperplasia
Background: Ageing and chronic exposure to androgens, mainly dihydrotestosterone, is required for the overgrowth of the prostate… 
2008
2008
Elocalcitol (BXL-628): a novel, investigational therapy for the therapeutic management of benign prostatic hyperplasia.
2006
2006
Oral treatment with a vitamin D3 analogue (BXL628) has anti‐inflammatory effects in rodent model of interstitial cystitis
To investigate the effects of a vitamin D3 analogue (BXL628) in a model of chronic cystitis, as calcitriol analogues might be an… 
2006
2006
Vitamin D analog BXL628 arrests prostate growth in patients with benign prostatic hyperplasia
Vitamin D analog BXL628 arrests prostate growth in patients with benign prostatic hyperplasia 
2006
2006
Smoking could influence prostate cancer progression via gene hypermethylation
Proliferation of prostate cells, as in benign prostatic hyperplasia (BPH), is inhibited by binding of agonists such as vitamin D3… 
2006
2006
Upper urinary tract surveillance in patients with stage Ta bladder cancer
Proliferation of prostate cells, as in benign prostatic hyperplasia (BPH), is inhibited by binding of agonists such as vitamin D3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)